Melius MicroBiomics Inc. (MMB)
The Gibson Lab created two genetically engineered microbial medicines (GEMM™), BioPersist™ & BioColonize™. Melius MicroBiomics Inc. has licensed this UBC IP to take these products to market. Dr. Deanna Gibson is the current CSO of MMB.
Learn more here
